News
TAIPEI (Taiwan News) — Taiwan’s Food and Drug Administration on Friday assured the public that an alternative vitamin A eye ...
Dry eye affects up to 16 million people in the US, and new treatments aim to mitigate the symptoms that can disrupt quality of life in these patients.
4d
The Mirror US on MSN23-year-old with 'extreme dry eye' treated with her own blood warns othersMelanie Saunders is urging people not to take their health for granted after having to drop out of nursing school due to her ...
Viridian is evaluating VRDN-001 in two global phase 3 clinical trials, THRIVE and THRIVE-2, for the treatment of active and chronic TED, respectively.
Top Cleveland Clinic and University of Iowa eye doctors explain it's not just blurry vision or irritation—and not just any ...
11d
The Healthy @Reader's Digest on MSN“How I Knew I Had Dry Eye”: One Patient’s Story of Frustrating Symptoms—with Simple Fixes"I spend eight to ten hours a day in front of a computer," she shares. Relate much? Here's how a woman in her fifties finally ...
Topline data were announced from a phase 3 trial evaluating ST-100 (vezocolmitide) ophthalmic solution for the treatment of dry eye disease (DED). ST-100 is a novel collagen mimetic peptide designed ...
Rose water, valued for centuries, offers several eye care benefits due to its anti-inflammatory, antimicrobial, and hydrating properties. It can relie ...
Stuart Therapeutics’ dry eye disease drug has failed to demonstrate that it can increase tear production in a phase 3 test.
Phase 2 results were positive for ILYX-002, a topical immunomodulator for moderate to severe dry eye disease associated with systemic autoimmune or inflammatory conditions, according to a press ...
Per FDA agreement, the only new clinical data included in the resubmitted NDA were from the recently completed dry eye chamber trial, which achieved the primary endpoint.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results